"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 0 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 3 | 5 |
| 2005 | 4 | 1 | 5 |
| 2006 | 1 | 1 | 2 |
| 2007 | 3 | 2 | 5 |
| 2008 | 2 | 0 | 2 |
| 2009 | 5 | 4 | 9 |
| 2010 | 5 | 8 | 13 |
| 2011 | 5 | 7 | 12 |
| 2012 | 6 | 5 | 11 |
| 2013 | 8 | 4 | 12 |
| 2014 | 5 | 4 | 9 |
| 2015 | 6 | 1 | 7 |
| 2016 | 5 | 4 | 9 |
| 2017 | 4 | 7 | 11 |
| 2018 | 10 | 7 | 17 |
| 2019 | 8 | 4 | 12 |
| 2020 | 4 | 7 | 11 |
| 2021 | 10 | 5 | 15 |
| 2022 | 0 | 10 | 10 |
| 2023 | 1 | 4 | 5 |
| 2024 | 6 | 7 | 13 |
| 2025 | 5 | 3 | 8 |
| 2026 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Healthcare insurance status and hypertension control before and after the Affordable Care Act. Am J Hypertens. 2026 Aug 01; 39(8):1013-1020.
-
Resistant Hypertension Variants Link to Hyperaldosteronism and Potassium Levels. Hypertension. 2026 Sep; 83(9):e22301.
-
Implementation of a Self-Measured Blood Pressure Pilot Program in an Academic Internal Medicine Practice. Am J Hypertens. 2026 05 01; 39(5):661-669.
-
Trends in Blood Pressure Control During the COVID-19 Pandemic: A Study of 17 US Health Systems in the National Patient-Centered Clinical Research Network Blood Pressure Control Laboratory. J Am Heart Assoc. 2026 04 21; 15(8):e045694.
-
Estimating the Hawthorne Effect in Real-World Blood Pressure Control Trials: An Analysis of the BP Home Trial. J Gen Intern Med. 2026 Sep; 41(12):3416-3426.
-
Population Health Approach to Blood Pressure Control Using Advanced Practice Provider-Managed Remote Patient Monitoring. J Healthc Qual. 2026 Jul-Sep 01; 48(3).
-
Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. J Gen Intern Med. 2026 05; 41(7):1881-1891.
-
Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults. Hypertension. 2025 11; 82(11):1857-1865.
-
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clin Pharmacol Ther. 2025 12; 118(6):1430-1436.
-
Relationship Between Third-Trimester Low Maternal Blood Pressure and Small-for-Gestational-Age Birth Weight in Pregnant Individuals With Mild Chronic Hypertension. Obstet Gynecol. 2025 Jul 10; 146(3):405-412.